Counselors in La Fayette, GA Accepting Medicare
8 Counselors found. Showing 1 - 8
 Gregory H Sadler, M.ED. Counselor - Professional Medicare: Medicare Enrolled Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-638-5591 Fax: 706-638-2055 |
 Ms. Beatrice Askew Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-628-5580 |
Charlotte Speed, CADC II Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-538-5580 Fax: 706-638-5445 |
Mr. Myron Russell Proctor, CADC, LMSW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, La Fayette, GA 30728 Phone: 678-590-5589 |
Morgan Boles Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 103 Margaret St, La Fayette, GA 30728 Phone: 678-590-5589 |
Megan Brackett Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-638-5591 |
Emily King Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-806-1120 |
Ms. Karyl D Baker, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 501 Mize St, La Fayette, GA 30728 Phone: 706-638-5580 |
News Archive
Transcranial magnetic stimulation that treats depression gains momentum
A new magnetic therapy that treats major depression "is rapidly gaining momentum," said Dr. Murali Rao of Loyola University Medical Center, one of the first Chicago-area centers to offer the treatment.
Millennium's sNDA for VELCADE granted priority review by the FDA
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
CyberKnife Robotic Radiosurgery treatment offers new option for cancer patients in Ontario
Ontario marks a milestone with the announcement of the province's first CyberKnife Robotic Radiosurgery treatment option for cancer patients at Juravinski Cancer Centre. The technology will offer many cancer patients an effective alternative to surgery for some cancers.
Hunk protein inhibition might provide new approach to treat HER2-positive breast cancer
Among women with breast cancer, approximately 25% have a subtype that is characterized by high levels of expression of the protein HER2. HER2-positive breast cancer tends to be more aggressive than other breast cancer subtypes.
Scientists discover that microRNAs regulate thousands of human genes
For many years, DNA and proteins have been viewed as the real movers and shakers in genomic studies, with RNA seen as little more than a messenger that shuttles information between the two.
› Verified 5 days ago
Counselors
Pharmacists
Dentists
Psychologists
Clinical Social Workers